Language: English
Physician profile
Dr. med. Eda Börner
Physician · Department of Pulmonary Medicine
Consultant, Department of Pulmonary Medicine · Ruhrlandklinik Essen
This profile summarises the career and qualifications of Dr. med. Eda Börner factually and with sources. The choice of physician and clinic always rests with the patient.
Profile summary and areas of expertise
Eda Börner is a consultant in the Department of Pulmonary Medicine at Ruhrlandklinik in Essen. Eda Börner holds clinics in the central outpatient department for patients with COPD and with interstitial and rare lung diseases. The publications of Eda Börner focus mainly on interstitial lung diseases in connective tissue diseases, sarcoidosis and pulmonary alveolar proteinosis.
- Interstitial and rare lung diseases
- Chronic obstructive pulmonary disease (COPD)
- Sarcoidosis
Clinical work and institutions
Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen (MedVici profile of the institution)
Klinik für Pneumologie
- currentConsultant
Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen (MedVici profile of the institution)
Zentralambulanz
- currentClinics for COPD and for interstitial and rare lung diseases
Qualifications and training
- 2018Doctorate (Dr. med.), University of Duisburg-Essen
Publications, talks and media
Documented contributions directly related to Dr. med. Eda Börner, grouped by type and listed newest first within each type. Every title links to the original source.
Specialist publications according to the author affiliation – no statement about treatment success or the quality of the institution. MedVici Health currently does not show cancer-related publications.
Doctoral thesis (1)
- Azathioprine in connective tissue disease-associated interstitial lung disease: data from a retrospective single centre study (original source, opens in a new window)
Dissertation, Universität Duisburg-Essen (Deutsche Nationalbibliothek)
Scientific publications (11)
- Toll interacting protein (TOLLIP) serum concentration in patients with systemic sclerosis (SSc), with and without interstitial lung disease (ILD) (original source, opens in a new window)
BMJ Open Respiratory Research (PubMed 42264885)
- Biodegradable Stents-A New Option for Benign Central Airway Stenosis (original source, opens in a new window)
Respirology (PubMed 40878035)
- Online survey on existing sarcoidosis registries and biobanks: an ERN lung initiative (original source, opens in a new window)
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases (PubMed 39655584)
- Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease (original source, opens in a new window)
Journal of Clinical Medicine (PubMed 36769819)
- Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF (original source, opens in a new window)
Orphanet Journal of Rare Diseases (PubMed 33639995)
- Pulmonary alveolar proteinosis: another autoimmune disease associated with sarcoidosis? (original source, opens in a new window)
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases (PubMed 27055841)
Contact via MedVici
Questions about this profile and about MedVici Health's services for patients are answered by MedVici Health. Please do not send medical reports or other health data by email — there is an encrypted channel for documents.
Disclosure: Ruhrlandklinik is listed on MedVici Health with a clinic profile. Its managing director, Jürgen Schlebrowski, is a member of the MedVici Health Board of Advisors.
Reference profile based on publicly available information. No business relationship with MedVici Health is implied or claimed.
MedVici Health does not refer patients to specific physicians; patients choose their physician and clinic themselves.
Professional details based on publicly available information from the institution and bibliographic records, as of 19.10.2026.